PRICE T ROWE ASSOCIATES INC /MD/
Position in FULC — Fulcrum Therapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in FULC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$344,900
-$269,996 QoQ
Shares Held
94,235
+17.5% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 154 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. FULC ranks #221 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in FULC
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $344,900 | 94,235 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $614,896 | 80,169 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $721,125 | 63,760 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $606,206 | 65,892 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $474,912 | 69,028 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $202,083 | 70,168 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $246,129 | 52,368 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $127,491 | 35,712 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $221,414 | 35,712 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $150,096 | 15,900 | Shares | Defined | 2024-05-15 | |
| 2023-09-30 | $70,596 | 15,900 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $69,960 | 21,200 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $103,913 | 36,461 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,095,705 | 150,509 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $360,854 | 44,605 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $145,613 | 29,717 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $596,098 | 25,205 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,383,815 | 134,755 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,252,524 | 44,400 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||